Back to search

Ireland· IE-PA-EU/1/18/1351/001-002

Trecondi 1 g powder for solution for infusion

A treosulfan product containing treosulfan, registered in Ireland by medac Gesellschaft für klinische Spezialpräparate mbH. The same ATC class is registered in 16 of our 19 countries.

ATC L01AB02

Checked against HPRA (Ireland) on

Informational only — not a medical device.

SOURCE REGISTER · IEHPRA (Ireland)normalisedTrecondi 1 g powder for solution for …ATCL01AB02REGISTER NO.IE-PA-EU/1/18/1351/00…PACKS LISTED1CHECKEDSeptember 28, 2026

Where it is registered

Treosulfan is registered in 16 of 19 countries.

Countries holding a registration under ATC L01AB02 (treosulfan), each read from that country’s own register.

  • This record: Ireland, from HPRA (Ireland)
  • 9 of them publish a price we can compare per daily dose

Treosulfan · ATC L01AB02

16 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

HPRA (Ireland)
Active substance
Treosulfan
Manufacturer
medac Gesellschaft für klinische Spezialpräparate mbH
Country
Ireland (IE)
ATC code
L01AB02
ATC class
Treosulfan
Reimbursed
Not published by this register
Source register
HPRA (Ireland)
Last checked
September 28, 2026

Packs & prices · 1

  • ie_pa_number
    EU/1/18/1351/001-002

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Treosulfan in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All treosulfan products

Authorised across Europe · EMA

The same active substance is authorised in 18 EEA countries. Names it is sold under:

  • Austria · Treosulfan Tillomed
  • Belgium · Treosulfan Tillomed
  • Czechia · Treosulfan Tillomed
  • Germany · Ovastat, Treosulfan Tillomed
  • Denmark · Treosulfan Tillomed
  • Spain · Treosulfano Zentiva
  • Finland · Treosulfan Tillomed
  • France · Treosulfan Tillomed
  • United Kingdom (Northern Ireland) · Treosulfan Tillomed Laboratories
  • Greece · Treosulfan Tillomed
  • Iceland · Trecondi
  • Liechtenstein · Trecondi
  • Netherlands · Treosulfan Tillomed
  • Norway · Trecondi, Treosulfan Tillomed
  • Poland · Treosulfan Zentiva
  • Portugal · Treossulfano Tillomed
  • Romania · Treosulfan Tillomed
  • Sweden · Treosulfan Tillomed

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/bececfd2-4220-4e77-876c-ec672ef3e439
GET /v1/drugs/bececfd2-4220-4e77-876c-ec672ef3e439?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Powder for solution for infusion",
  "routes": [
    "Intravenous use"
  ],
  "source": "hpra",
  "atc_all": [
    "L01AB",
    "L01AB02"
  ],
  "strength": null,
  "pa_number": "EU/1/18/1351/001-002",
  "substances": [
    "Treosulfan"
  ],
  "legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
  "market_info": "Unknown",
  "authorised_at": "20/06/2019",
  "dispensing_status": "Product subject to prescription which may not be renewed (A)",
  "registration_status": "AU",
  "supply_legal_status": "Supply through pharmacies only",
  "interchangeable_code": null
}

See everything about treosulfan.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.